Drug Profile
AD 8210
Alternative Names: AD-8210Latest Information Update: 05 Jun 2001
Price :
$50
*
At a glance
- Originator Dainippon Pharmaceutical
- Class Antiemetics; Gastrokinetics
- Mechanism of Action Dopamine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Nausea and vomiting
Most Recent Events
- 05 Jun 2001 Discontinued-Preclinical for Emesis in Japan (Unknown route)
- 13 Oct 1997 Preclinical development for Emesis in Japan (Unknown route)